98 related articles for article (PubMed ID: 6220269)
1. [Gynecomastia: effect of prolonged treatment with dihydrotestosterone by the percutaneous route].
Kuhn JM; Laudat MH; Roca R; Dugue MA; Luton JP; Bricaire H
Presse Med; 1983 Jan; 12(1):21-5. PubMed ID: 6220269
[TBL] [Abstract][Full Text] [Related]
2. Studies on the treatment of idiopathic gynaecomastia with percutaneous dihydrotestosterone.
Kuhn JM; Roca R; Laudat MH; Rieu M; Luton JP; Bricaire H
Clin Endocrinol (Oxf); 1983 Oct; 19(4):513-20. PubMed ID: 6354523
[TBL] [Abstract][Full Text] [Related]
3. [Testosterone and estradiol levels in male gynecomastia. Clinical and endocrine findings during treatment with tamoxifen].
Eversmann T; Moito J; von Werder K
Dtsch Med Wochenschr; 1984 Nov; 109(44):1678-82. PubMed ID: 6489180
[TBL] [Abstract][Full Text] [Related]
4. Successful percutaneous dihydrotestosterone treatment of gynecomastia occurring during highly active antiretroviral therapy: four cases and a review of the literature.
Benveniste O; Simon A; Herson S
Clin Infect Dis; 2001 Sep; 33(6):891-3. PubMed ID: 11512095
[TBL] [Abstract][Full Text] [Related]
5. Role of testosterone and dihydrotestosterone in spontaneous gynecomastia of adolescents.
Villalpando S; Mondragón L; Barrón C; Pérez-Pastén E; Castañeda G; Alonso-Uriarte R; Cortés-Gallegos V
Arch Androl; 1992; 28(3):171-6. PubMed ID: 1530365
[TBL] [Abstract][Full Text] [Related]
6. [Hormonal profile of idiopathic gynecomastia in young adults. Apropos of 488 cases].
Bauduceau B; Reboul P; Le Guyadec T; Legrelle M; Mayaudon H; Gautier D
Ann Endocrinol (Paris); 1993; 54(3):163-7. PubMed ID: 8024242
[TBL] [Abstract][Full Text] [Related]
7. Impact level of dihydrotestosterone on the hypothalamic-pituitary-leydig cell axis in men.
Cailleux-Bounacer A; Rohmer V; Lahlou N; Lefebvre H; Roger M; Kuhn JM
Int J Androl; 2009 Feb; 32(1):57-65. PubMed ID: 17931384
[TBL] [Abstract][Full Text] [Related]
8. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty.
Keenan BS; Richards GE; Ponder SW; Dallas JS; Nagamani M; Smith ER
J Clin Endocrinol Metab; 1993 Apr; 76(4):996-1001. PubMed ID: 8473416
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.
Idan A; Griffiths KA; Harwood DT; Seibel MJ; Turner L; Conway AJ; Handelsman DJ
Ann Intern Med; 2010 Nov; 153(10):621-32. PubMed ID: 21079217
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous absorption of 5 alpha-dihydrotestosterone in man. II. Percutaneous administration of 5 alpha-dihydrotestosterone in hypogonadal men with idiopathic haemochromatosis; clinical, metabolic and hormonal effectiveness.
Chemana D; Morville R; Fiet J; Villette JM; Tabuteau F; Brerault JL; Passa P
Int J Androl; 1982 Dec; 5(6):595-606. PubMed ID: 7160922
[TBL] [Abstract][Full Text] [Related]
11. Male patients with partial androgen insensitivity syndrome: a longitudinal follow-up of growth, reproductive hormones and the development of gynaecomastia.
Hellmann P; Christiansen P; Johannsen TH; Main KM; Duno M; Juul A
Arch Dis Child; 2012 May; 97(5):403-9. PubMed ID: 22412043
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of breast enlargement in young males and factors associated with gynecomastia and pseudogynecomastia.
Yazici M; Sahin M; Bolu E; Gok DE; Taslipinar A; Tapan S; Torun D; Uckaya G; Kutlu M
Ir J Med Sci; 2010 Dec; 179(4):575-83. PubMed ID: 19495841
[TBL] [Abstract][Full Text] [Related]
13. [A new antigonadotropin in the treatment of precocious puberty and pubertal gynaecomastia (author's transl)].
Swoboda W; Turnheim E; Frisch H; Spona J
Padiatr Padol Suppl; 1977; (5):109-20. PubMed ID: 199873
[TBL] [Abstract][Full Text] [Related]
14. Effects of 10 days administration of percutaneous dihydrotestosterone on the pituitary-testicular axis in normal men.
Kuhn JM; Rieu M; Laudat MH; Forest MG; Pugeat M; Bricaire H; Luton JP
J Clin Endocrinol Metab; 1984 Feb; 58(2):231-5. PubMed ID: 6363434
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen for flutamide/finasteride-induced gynecomastia.
Staiman VR; Lowe FC
Urology; 1997 Dec; 50(6):929-33. PubMed ID: 9426725
[TBL] [Abstract][Full Text] [Related]
16. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozole.
Riepe FG; Baus I; Wiest S; Krone N; Sippell WG; Partsch CJ
Horm Res; 2004; 62(3):113-8. PubMed ID: 15273427
[TBL] [Abstract][Full Text] [Related]
18. Gynaecomastia associated with cimetidine.
Spence RW; Celestin LR
Gut; 1979 Feb; 20(2):154-7. PubMed ID: 428828
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of marked gynecomastia in puberty with tamoxifen].
König R; Schönberger W; Neumann P; Benes P; Grimm W
Klin Padiatr; 1987; 199(6):389-91. PubMed ID: 3123765
[TBL] [Abstract][Full Text] [Related]
20. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
